Favorable market conditions reward Kaneka's patience in the PHA market

June 20, 2019 | Case Study

Kaneka's involvement with polyhydroxyalkanoates (PHAs) extends back to the early 2000s. In 2002, the company applied for a patent on the preparation of biodegradable fibers from PHB, PHBH, and PHBV. Then, in 2004, Kaneka and P&G Chemicals formed a joint development partnership leading to the commercialization of Nodax PHBH. While Kaneka and P&G planned to pursue the scale-up of Nodax in 2006 for flexible applications, the two never fulfilled these plans. Instead, P&G sold some of its IP to Meridian (now Danimer Scientific). A few years later, Kaneka's R&D activity into PHAs and downstream applications took a back seat (see Kaneka's PHA patent activity below), allowing players like Bio-On and Danimer to take center stage.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978